Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Posted on April 18, 2020 by

Allergy. 2020 Sep;75(9):2376-2379. doi: 10.1111/all.14324. Epub 2020 May 5.

NO ABSTRACT

PMID:32302412 | PMC:PMC7540274 | DOI:10.1111/all.14324

This entry was posted in Uncategorized. Bookmark the permalink.